415 related articles for article (PubMed ID: 30283822)
1. Regulatory Status of Cannabidiol in the United States: A Perspective.
Corroon J; Kight R
Cannabis Cannabinoid Res; 2018; 3(1):190-194. PubMed ID: 30283822
[TBL] [Abstract][Full Text] [Related]
2. Cannabidiol and Other Cannabinoids: From Toxicology and Pharmacology to the Development of a Regulatory Pathway.
Koturbash I; MacKay D
J Diet Suppl; 2020; 17(5):487-492. PubMed ID: 32715797
[TBL] [Abstract][Full Text] [Related]
3. Legal and Regulatory Issues Governing Cannabis and Cannabis-Derived Products in the United States.
Mead A
Front Plant Sci; 2019; 10():697. PubMed ID: 31263468
[TBL] [Abstract][Full Text] [Related]
4. Current legal status of medical marijuana and cannabidiol in the United States.
Alharbi YN
Epilepsy Behav; 2020 Nov; 112():107452. PubMed ID: 32956945
[TBL] [Abstract][Full Text] [Related]
5. Differentiating Full-Spectrum Hemp Extracts from CBD Isolates: Implications for Policy, Safety and Science.
Marinotti O; Sarill M
J Diet Suppl; 2020; 17(5):517-526. PubMed ID: 32543253
[TBL] [Abstract][Full Text] [Related]
6. The legal status of cannabis (marijuana) and cannabidiol (CBD) under U.S. law.
Mead A
Epilepsy Behav; 2017 May; 70(Pt B):288-291. PubMed ID: 28169144
[TBL] [Abstract][Full Text] [Related]
7. Cannabidiol - therapeutic and legal aspects.
Vlad RA; Hancu G; Ciurba A; Antonoaea P; Rédai EM; Todoran N; Silasi O; Muntean DL
Pharmazie; 2020 Oct; 75(10):463-469. PubMed ID: 33305718
[TBL] [Abstract][Full Text] [Related]
8. A Cross-Sectional Study of Cannabidiol Users.
Corroon J; Phillips JA
Cannabis Cannabinoid Res; 2018; 3(1):152-161. PubMed ID: 30014038
[No Abstract] [Full Text] [Related]
9. Cannabinoid Content and Label Accuracy of Hemp-Derived Topical Products Available Online and at National Retail Stores.
Spindle TR; Sholler DJ; Cone EJ; Murphy TP; ElSohly M; Winecker RE; Flegel RR; Bonn-Miller MO; Vandrey R
JAMA Netw Open; 2022 Jul; 5(7):e2223019. PubMed ID: 35857320
[TBL] [Abstract][Full Text] [Related]
10. Clinicians' Guide to Cannabidiol and Hemp Oils.
VanDolah HJ; Bauer BA; Mauck KF
Mayo Clin Proc; 2019 Sep; 94(9):1840-1851. PubMed ID: 31447137
[TBL] [Abstract][Full Text] [Related]
11. Cannabidiol or CBD Oil: Help, Hope, and Hype for Psychiatric and Neurologic Conditions.
Newton M; Newton DW
J Am Psychiatr Nurses Assoc; 2020; 26(5):447-457. PubMed ID: 32508204
[No Abstract] [Full Text] [Related]
12. The Impact of Cannabidiol on Psychiatric and Medical Conditions.
Oberbarnscheidt T; Miller NS
J Clin Med Res; 2020 Jul; 12(7):393-403. PubMed ID: 32655732
[TBL] [Abstract][Full Text] [Related]
13. The Surprising Reach of FDA Regulation of Cannabis, Even After Descheduling.
O'Connor SM; Lietzan E
Am Univ Law Rev; 2019; 68(3):823-925. PubMed ID: 30919712
[TBL] [Abstract][Full Text] [Related]
14. CANNABINOID CONUNDRUM:: A STUDY OF MARIJUANA AND HEMP LEGALITY IN THE UNITED STATES.
Dickson K; Janasie C; Willett KL
Arizona J Environ Law Policy; 2019; 10(20):132-150. PubMed ID: 34007734
[TBL] [Abstract][Full Text] [Related]
15. Social media surveillance for perceived therapeutic effects of cannabidiol (CBD) products.
Tran T; Kavuluru R
Int J Drug Policy; 2020 Mar; 77():102688. PubMed ID: 32092666
[TBL] [Abstract][Full Text] [Related]
16. A Review of Human Studies Assessing Cannabidiol's (CBD) Therapeutic Actions and Potential.
White CM
J Clin Pharmacol; 2019 Jul; 59(7):923-934. PubMed ID: 30730563
[TBL] [Abstract][Full Text] [Related]
17. Health Claims About Cannabidiol Products: A Retrospective Analysis of U.S. Food and Drug Administration Warning Letters from 2015 to 2019.
Wagoner KG; Lazard AJ; Romero-Sandoval EA; Reboussin BA
Cannabis Cannabinoid Res; 2021 Dec; 6(6):559-563. PubMed ID: 34142863
[No Abstract] [Full Text] [Related]
18. Emerging challenges in the extraction, analysis and bioanalysis of cannabidiol and related compounds.
Brighenti V; Protti M; Anceschi L; Zanardi C; Mercolini L; Pellati F
J Pharm Biomed Anal; 2021 Jan; 192():113633. PubMed ID: 33039911
[TBL] [Abstract][Full Text] [Related]
19. Integrative Medicine: Cannabis and Cannabis-Related Drugs.
Moss DA; Hawks MK; Snyder MJ; Crawford PF
FP Essent; 2021 Jun; 505():28-34. PubMed ID: 34128629
[No Abstract] [Full Text] [Related]
20. Assessment of hemp oil-based cannabidiol use in a community-based pharmacy setting.
Gicewicz E; Gatewood SS; Kaefer TN; Nadpara P; Goode JR
J Am Pharm Assoc (2003); 2021; 61(4S):S49-S56. PubMed ID: 33745856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
